Search
for
Sort by
Research 931–960 of 1000+
- Immunogenetic and metabolic risk factors in male androgenetic alopecia: the role of HLA-DRB1 alleles and vitamin D3 deficiency
- Efficacy and safety of topical GT20029 in male patients with androgenetic alopecia: a multicenter, randomized, double-blind, placebo-controlled phase 2 study
- Increased Prevalence of Insulin Resistance and Metabolic Syndrome in Men With Early‐Onset Androgenetic Alopecia: A Case–Control Study
- Personalized Platelet Rich Plasma (PRP) treatment for androgenetic alopecia: A comprehensive case study
- Platelet Rich Plasma as Monotherapy in Androgenetic Alopecia
- Efficacy of Platelet Rich Plasma and Concentrated Growth Factor in Treating Androgenetic Alopecia: A Split-Scalp Study
- LB1139 AMP-303 injectable treatment for androgenetic alopecia: A multicenter, randomized, placebo-controlled feasibility study of a novel polysaccharide
- 0951 Breezula, a clinical stage topical anti-androgen, promotes dermal papilla inductivity and reduces IL-6 secretion in balding skin samples ex vivo
- Management of Khalitya (Male pattern hair loss) through prachanna followed by chitrakadi lepa - A case report
- Effects of platelet-rich plasma application on hair follicle count, telogen/anagen ratio, and miniaturized hair ratio in patients with androgenic alopecia: alone or in combination with other treatments
- The Possible Bidirectional Relationship between Disease Severity in Androgenetic Alopecia and Seborrheic Dermatitis: A Cross-Sectional Study in a Tertiary Care Hospital
- Evaluation of the effectiveness of fractional lasers in the treatment of androgenetic alopecia: a literature review
- Glutathione S-transferase gene polymorphism, total antioxidant status, and blood pressure changes in androgenic alopecia
- Comparative study of platelet rich plasma therapy versus microneedling as a treatment modality for androgenetic alopecia
- Subcutaneous versus combined subcutaneous and intramuscular botulinum toxin for androgenetic alopecia: a randomized clinical trial
- Baseline hair loss severity as a potential confounder in studies on minoxidil and low-level laser therapy
- Oral minoxidil 2.5 mg versus 5 mg for treatment of male androgenetic alopecia: a double-blind randomized clinical trial
- Development of Multiple Cherry Haemangiomas in a Patient with Androgenetic Alopecia after Topical Minoxidil Use
- Comprehensive Evaluation of Androgenetic Alopecia: Demographic Characteristics, Psychosocial Impact, and the Role of Social Media in Treatment Choices
- Impact of male androgenetic alopecia on a Jordanian cohort measured using the Dermatology Life Quality Index
- Prepubertal Fibrosing Alopecia in a Pattern Distribution
- Effectiveness of Combined Oral Minoxidil and Finasteride in Male Androgenetic Alopecia: A Retrospective Service Evaluation
- Frequency of Types of Alopecia in a Single-centre Hair Referral Clinic Over a Ten Years Period
- Photobiostimulation Therapy (PBST) and Pulsed Electromagnetic Field Therapy (PEMF) in Hair Loss Treatment: Multicentric, Retrospective, Case–Control Study
- Autologous Micrografts Containing Nanovesicles, Exosomes, and Follicle Stem Cells in Androgenetic Alopecia: In Vitro and In Vivo Analysis Through a Multicentric, Observational, Evaluator-Blinded Study
- Androgenic Alopecia Is Associated With More Severe Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
- Hair restoration surgery: pre-surgical considerations and pitfalls
- Low-level light therapy versus topical 5% minoxidil in the management of androgenetic alopecia in males: A randomised controlled trial
- Utilising SNP Association Analysis as a Prospective Approach for Personalising Androgenetic Alopecia Treatment
- Diagnostic and grading criteria for androgenetic alopecia using dermoscopy